机译:Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit/Hyperactivity Disorder
Shire Pharmaceut, Wayne, PA 19087 USA;
Anal Grp Inc, Boston, MA USA;
Anal Grp Inc, New York, NY USA;
attention deficit/hyperactivity disorder; lisdexamphetamine dimesylate; personalized treatment selection; treatment individualization;